Literature DB >> 1920748

Evidence for the effects of HIV antibody counseling and testing on risk behaviors.

D L Higgins1, C Galavotti, K R O'Reilly, D J Schnell, M Moore, D L Rugg, R Johnson.   

Abstract

OBJECTIVE: To review published abstracts, journal articles, and presentations for evidence of the effects of human immunodeficiency virus (HIV) antibody counseling and testing on risk behaviors. Studies reviewed focused on homosexual men, intravenous drug users in treatment programs, pregnant women, and other heterosexuals. DATA SOURCES: Peer-reviewed journals (January 1986 through July 1990) and published abstracts and oral presentations from the second (1986) through the sixth (1990) International Conferences on AIDS. STUDY SELECTION: We identified 66 studies that included data on the behavioral effects of HIV antibody counseling and testing. By consensus of the authors, 16 of these were excluded because of small sample size or inadequate study design. DATA EXTRACTION: Studies were assessed by the authors according to methodological strength (sample selection, inclusion of appropriate comparison groups, and inclusion of statistical tests of significance). DATA SYNTHESIS: All longitudinal studies of homosexual men reported reductions in risky behavior among both tested and untested men, and a few reported greater decreases among seropositive men than among seronegative men and those untested or unaware of their serostatus. For intravenous drug users in treatment, we found reductions in intravenous drug use and sexual risk behaviors regardless of counseling and testing experience. We found little evidence for the impact of counseling and testing on pregnancy and/or pregnancy termination rates for either seropositive or seronegative high-risk women. We noted substantial risk reduction among heterosexual couples with one infected partner. Findings among other heterosexuals at increased risk were scanty and mixed.
CONCLUSIONS: Further studies should specifically address the behavioral consequences of counseling and testing in various settings.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920748

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  84 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Implementing a syphilis elimination and importation control strategy in a low-incidence urban area: San Diego County, California, 1997-1998.

Authors:  R A Gunn; S L Harper; D E Borntrager; P E Gonzales; M E St Louis
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996.

Authors:  J E Anderson; J W Carey; S Taveras
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 4.  Technology and effect: HIV/AIDS testing in Brazil.

Authors:  J Biehl; D Coutinho; A L Outeiro
Journal:  Cult Med Psychiatry       Date:  2001-03

5.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

6.  The efficacy of a relationship-based HIV/STD prevention program for heterosexual couples.

Authors:  Nabila El-Bassel; Susan S Witte; Louisa Gilbert; Elwin Wu; Mingway Chang; Jennifer Hill; Peter Steinglass
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

7.  Denver's increase in HIV counseling after Magic Johnson's HIV disclosure.

Authors:  D L Cohn; L A Miller; K J Yamaguchi; J M Douglas
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

8.  The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.

Authors:  R S Janssen; D R Holtgrave; R O Valdiserri; M Shepherd; H D Gayle; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

9.  Demographic and behavioral predictors of knowledge and HIV seropositivity: results of a survey conducted in three anonymous and free counselling and testing centers.

Authors:  I Momas; H Helal; S Prétet; L Marsal; R Poinsard
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

10.  Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.

Authors:  E J van Ameijden; A R van den Hoek; R A Coutinho
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.